Grabar Law Office In the News:Â Â Alto Neuroscience Execs Sued Over Rosy Drug Claims
By Grabar Law |
An Alto Neuroscience investor claims CEO Amit Etkin and other directors overstated the efficacy of the psychiatric biotech company's lead ...
Read More 
Grabar Law Office In the News:Â Â Marijuana Vape Antitrust Actions Consolidated In Calif.
By Grabar Law |
Five proposed antitrust class actions brought by buyers of CCell brand cannabis vape accusing the Chinese manufacturers and U.S. distributors ...
Read More 
Grabar Law Office In the News:Â Â DOJ Asks for Stay in PVC Antitrust Case Amid Criminal Probe
By Grabar Law |
The U.S. Department of Justice is asking an Illinois federal court to pause discovery in a case accusing polyvinyl chloride ...
Read More 
Grabar Law Office In the News: Biotech Replimune Faces Derivative Suit Over Trial Claims
By Grabar Law |
Executives and directors of biotechnology company Replimune Group Inc. face shareholder derivative claims that they concealed issues affecting a clinical ...
Read More 
Grabar Law Office Files Federal Lawsuit Against Major Insulin Manufacturers and PBMs on Behalf of the University of Pennsylvania
By Grabar Law |
Grabar Law Office has filed a complaint on behalf of The Trustees of the University of Pennsylvania in the United ...
Read More 
Grabar Law Office In the News: Â Geron Shareholder Sues Execs Over Drug Launch Claims
By Grabar Law |
A shareholder of Geron Corp. has filed a derivative suit against current and former members of the biopharmaceutical company's top ...
Read More 
Grabar Law Office In the News: Â AI Audio Co. Brass Accused of Acquisition Accounting Errors
By Grabar Law |
Executives and directors of California-based voice recognition technology company SoundHound Inc. were hit with a shareholder derivative suit alleging they ...
Read More 
Grabar Law Office In The News: Block’s Dorsey, Others Face Derivative Suit Over AML Woes
By Grabar Law |
Officers and directors of Square and Cash App parent company Block Inc. face a shareholder derivative complaint over alleged anti-money ...
Read More 
Grabar Law Office In The News: Micron CEO Accused Of Insider Trading In Fla. Investor Suit
By Grabar Law |
A Micron Technology Inc. shareholder has accused the company CEO and several board members of insider trading after selling $70 million worth ...
Read More 
GRABAR LAW OFFICE IN THE NEWS: Â Biotech Co.’s Facility Failures Lost Investors Money, Suit Says
By Grabar Law |
The executives and directors of biotechnology company Humacyte Inc. have been hit with a shareholder derivative suit in North Carolina ...
Read More